WO2008124589A2 - Microfluidic device - Google Patents

Microfluidic device Download PDF

Info

Publication number
WO2008124589A2
WO2008124589A2 PCT/US2008/059408 US2008059408W WO2008124589A2 WO 2008124589 A2 WO2008124589 A2 WO 2008124589A2 US 2008059408 W US2008059408 W US 2008059408W WO 2008124589 A2 WO2008124589 A2 WO 2008124589A2
Authority
WO
WIPO (PCT)
Prior art keywords
comprises
channel
fluid
filter
detection system
Prior art date
Application number
PCT/US2008/059408
Other languages
French (fr)
Other versions
WO2008124589A3 (en
Inventor
Yu-Chong Tai
Siyang Zheng
Jeffrey Chun-Hui Lin
Harvey L. Kasdan
Original Assignee
California Institute Of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US92229607P priority Critical
Priority to US60/922,296 priority
Application filed by California Institute Of Technology filed Critical California Institute Of Technology
Publication of WO2008124589A2 publication Critical patent/WO2008124589A2/en
Publication of WO2008124589A3 publication Critical patent/WO2008124589A3/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502761Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads, for physically stretching molecules
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502753Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by bulk separation arrangements on lab-on-a-chip devices, e.g. for filtration or centrifugation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/06Fluid handling related problems
    • B01L2200/0636Focussing flows, e.g. to laminate flows
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/06Fluid handling related problems
    • B01L2200/0647Handling flowable solids, e.g. microscopic beads, cells, particles
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/06Auxiliary integrated devices, integrated components
    • B01L2300/0627Sensor or part of a sensor is integrated
    • B01L2300/0636Integrated biosensor, microarrays
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/06Auxiliary integrated devices, integrated components
    • B01L2300/0627Sensor or part of a sensor is integrated
    • B01L2300/0654Lenses; Optical fibres
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/06Auxiliary integrated devices, integrated components
    • B01L2300/0681Filter
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0809Geometry, shape and general structure rectangular shaped
    • B01L2300/0816Cards, e.g. flat sample carriers usually with flow in two horizontal directions
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0809Geometry, shape and general structure rectangular shaped
    • B01L2300/0822Slides
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0861Configuration of multiple channels and/or chambers in a single devices
    • B01L2300/0864Configuration of multiple channels and/or chambers in a single devices comprising only one inlet and multiple receiving wells, e.g. for separation, splitting
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0861Configuration of multiple channels and/or chambers in a single devices
    • B01L2300/0877Flow chambers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/08Regulating or influencing the flow resistance
    • B01L2400/084Passive control of flow resistance
    • B01L2400/086Passive control of flow resistance using baffles or other fixed flow obstructions
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N15/1056Microstructural devices for other than electro-optical measurement
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N15/14Electro-optical investigation, e.g. flow cytometers
    • G01N15/1484Electro-optical investigation, e.g. flow cytometers microstructural devices
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N2015/1006Investigating individual particles for cytology
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N15/14Electro-optical investigation, e.g. flow cytometers
    • G01N2015/1486Counting the particles
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N15/14Electro-optical investigation, e.g. flow cytometers
    • G01N2015/149Sorting the particles
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/11Automated chemical analysis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/13Tracers or tags
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/2575Volumetric liquid transfer

Abstract

Described herein are particular embodiments relating to a microfluidic device that may be utilized for cell sensing, counting, and/or sorting. Particular aspects relate to a microfabricated device that is capable of differentiating single cell types from dense cell populations. One particular embodiment relates a device and methods of using the same for sensing, counting, and/or sorting leukocytes from whole, undiluted blood samples.

Description

MICROFLUIDIC DEVICE

CROSS-REFERENCE TO RELATED APPLICATIONS The present application claims the benefit of U.S. provisional patent application serial No. 60/922,296, filed April 6, 2007.

STATEMENT OF GOVERNMENT INTEREST

This work was supported in part by the National Space Biomedical Research Institute through NASA, grant number NCC 9-58-317. The United States government has certain rights in this invention.

FIELD OF THE INVENTION

The present disclosure relates to fabricated microfluidic devices that can be utilized as cell sensors and/or actuators. In certain embodiments, the microfluidic device may be used for labeling, sensing, differentiating, and/or sorting targets, particularly cell populations.

BACKGROUND OF THE INVENTION

Standard cell sensors or actuators are generally based on flow cytometry and employ one or a combination of electrical impedance sensing, light scattering measurement, and chemical or immunostaining followed by optical sensing.

For differentiation of blood cells by electrical impedance sensing, red blood cells are removed by lysing in order to reduce the blood volume. Lysing is generally done through the use of saponin or surfactants. During the lysing process, the leukocyte cell volume changes depending on cell type, due to the leakage of cytoplasm contents and cell nucleus shrinkage in varying amounts. Fujimoto, Sysmex J. Int. 9 (1999). Thus, normally 2-part (lymphocytes versus granulocytes) or even 3-part (lymphocytes, neutrophils, and other leukocytes) differential can be achieved by simple electrical impedance measurement of particle volume. Hughes-Jones, et al., J. Clin. Pathol. 27; 623-625 (1974); Oberjat, et al., J. Lab. Clin. Med. 76; 518 (1970); Vandilla, et al., Proc. Soc. Exp. Biol. Med. 125; 367 (1967); Maeda, et al., CHn. Pathol. 27; 1117-1200 (1979); Maeda, et al., Clin. Pathol. 9; 555-558 (1982). Combining direct current and alternating current impedance, special acidic hemolysis in basophile channel and alkali hemolysis in eosinophil channel, a 5-part leukocyte differential can be achieved. Tatsumi, et al., Sysmex J. Int. 9; 9-20 (1999).

Alternative optical methods are based on light scattering and fluorescence staining of organelles, granules, and nuclei. Generally, low-angle scattered light contains information on cell size and high-angle scattered light can be used to probe internal composition of the cell. To achieve 5-part differential, certain leukocyte populations, such as eosinophils, require special stain to change its scattering characteristics from other granulocytes, and basophils typically need to be counted separately following the differential lysis of other leukocytes. McKenzie, Clinical Laboratory Hematology, Prentice Hall, 2004; Fujimoto, Sysmex J. Int. 9 (1999).

In general, conventional automated cell analyzers are bulky, expensive, and mechanically complex, which restricts their locations to hospitals or central laboratories. Conventional cell analyzers require larger sample volumes and generate more waste than the systems developed using microdevices. Furthermore, for analysis of certain cell types, such as leukocytes, accuracy and speed of counting, differentiation, and/or sorting is important for determining disease state and treatment.

BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWING(S)

FIG. 1A shows the molecular structure of acridine orange. FIG. 1 B shows leukocyte staining results with acridine orange. FIG. 2 shows the top view of one embodiment of a novel fabricated microfluidic apparatus.

FIG. 3 shows one embodiment of the optical system setup.

FIG. 4A shows erythrocyte concentration in whole blood. FIG. 4B shows leukocyte staining in whole blood with acridine orange at a concentration of 100 ng/mL.

FIG. 4C shows leukocyte staining in whole blood with acridine orange at a concentration of 1 μg/mL.

FIG. 4D shows leukocyte staining in whole blood with acridine orange at a concentration of 10 μg/mL.

FIG. 4E shows leukocyte staining in whole blood with acridine orange at a concentration of 100 μg/mL.

FIG. 4F shows leukocyte staining in whole blood with acridine orange at a concentration of 1 mg/mL. FIG. 5 shows fluorescent signal bleaching from a single leukocyte in one embodiment.

FIG. 6A shows an image of background and a 5 μm bead with focused laser illumination flow taken by CCD camera with long pass emission filter, according to one embodiment. FIG. 6B shows an image of background and a 5 μm bead with laser illumination flow taken by CCD camera with long pass emission filter, according to one embodiment.

FIG. 6C shows an image of background and a 5 μm bead with diffused laser illumination flow taken by CCD camera with long pass emission filter, according to one embodiment.

FIG. 6D shows an image of background and the trace of a 5 μm bead with diffused laser illumination flow taken by CCD camera with long pass emission filter, according to one embodiment. FIG. 7 shows a graph of detection of 5 μm fluorescent beads detection with photodiode detector with long pass emission filter.

FIG. 8A shows background image of focused laser beam from video taken by

CCD camera with long pass emission filter, according to one embodiment. FIG. 8B shows a signal from a leukocyte from diluted whole blood testing from video taken by CCD camera with long pass emission filter, according to one embodiment.

FIG. 9 shows the time trace of amplified photodiode signal of acridine orange stained undiluted whole blood with green emission filter centered at 525 nm, and peaks labeled, according to one embodiment.

FIG. 10 shows a histogram of signal intensity from photodiode detector with green emission filter centered at 525 nm.

FIG. 11 shows a histogram of signal intensity from photodiode detector with red emission filter centered at 650 nm. FIG. 12A shows an illustration of a handheld detection box instrument according to one embodiment.

FIG. 12B shows an assembled detection box instrument according to one embodiment.

FIG. 13A shows the top view of an apparatus according to one particular embodiment.

FIG. 13B shows the top view of an apparatus according to one particular embodiment.

SUMMARY OF THE INVENTION

Certain embodiments disclosed herein include a microfluidic apparatus comprising a substrate having a first channel having a defined physical feature, wherein said first channel is in fluid communication with at least one inlet for receiving a fluid, wherein said first channel leads to a restrictive access, and wherein said first channel is in fluid communication with a second channel having a defined physical feature, wherein said second channel is in fluid communication with at least one fluid flow outlet; and a fluid biological sample. In certain embodiments, said defined physical feature is a depression or protrusion. In particular embodiments, said fluid biological sample comprises blood. In certain embodiments, the microfluidic apparatus further comprises a detection zone, and/or a filter array, each in fluid communication with said channel and said fluid flow outlet.

A microfluidic apparatus comprising a substrate having at least one first channel having a defined physical feature; at least one first inlet formed in said first channel for receiving a first fluid; wherein said first channel is in fluid communication with a bifurcated channel, wherein said bifurcated channel is in fluid communication with a third channel detection zone; at least one second inlet for receiving a second fluid, wherein said second inlet is in fluid communication with a branched channel; a filter structure in fluid communication with a reservoir, wherein said reservoir is in fluid communication with said third channel detection zone; at least one fluid flow outlet formed in said third channel", and a fluid sample; wherein the ratio of the cross-sectional area of said second channel compared to the cross-sectional area of said first channel is 1:10. In certain embodiments, the defined physical feature is a depression or a protrusion. In certain embodiments, said filter structure comprises a filter array, said first fluid comprises sheath fluid and said second fluid comprises blood.

Certain embodiments disclosed herein relate to a detection system comprising a microfluidic apparatus and further comprising a light source; a lens assembly; a filter assembly; and an image capture device. In some embodiments, the detection system further comprises at least one display unit or at least one recording unit. In certain particular embodiments, said excitation source comprises a laser, particularly an argon laser. In particular embodiments, said filter assembly comprises an excitation filter, and at least one emission filter. In certain embodiments, said filter assembly further comprises at least one aperture and at least one neutral density filter. In particular embodiments, said filter assembly further comprises at least one glass polarizer.

In certain embodiments, the lens assembly of the detection system comprises at least one condenser lens, at least one objective lens, and at least one beamsplitter. In particular embodiments, said image capture device comprises at least one CCD camera, CMOS device, photodiode, or photomultiplier tube. In certain embodiments, said filter assembly comprises at least two emission filters and said image capture device comprises at least one photomultiplier tube. In certain embodiments, said display unit comprises a computer and said recording unit comprises an oscilloscope. In particular embodiments, said excitation source comprises an argon laser; said lens assembly comprises a condenser lens, an objective lens, and a beamsplitter; said filter assembly comprises an excitation filter, a pinhole aperture and a neutral density filter, and at least one emission filter; said image capture device comprises a CCD camera and a photodiode, and said display unit comprises a personal computer, and further comprising an amplifier.

In particular embodiments, said excitation source of the detection system comprises an argon laser; said lens assembly comprises a condenser lens, an objective lens, and a beamsplitter, said filter assembly comprises an excitation filter, at least one emission filter; said image capture device comprises a photomultiplier tube, and said display unit comprises a personal computer.

Other embodiments disclosed herein relate to a method for identifying a target comprising providing a fluid sample to at least one microfluidic apparatus, wherein said fluid sample contains at least one dye; providing an excitation source to induce at least one fluorescent signal in a target; detecting the fluorescent signal using a sensor in the apparatus; and identifying the target based in part on the analysis of the fluorescent signal. In certain embodiments, said target is selected from the group consisting of: cells, organelles, nuclei, granules, DNA, and RNA. In other embodiments, said target comprises a cell selected from the group consisting of a monocyte, a granulocyte, a macrophage, a neutrophil, an eosinophil, a basophil, or other leukocyte. In specific embodiments, said target comprises a leukocyte and said dye comprises acridine orange. Particular embodiments of the method further comprising counting or sorting the target in the sample by analysis of the fluorescent signal. In certain embodiments, said fluid sample comprises blood.

DETAILED DESCRIPTION OF THE INVENTION

The present disclosure relates to fabricated microfluidic devices that can be utilized as cell sensors and/or actuators. In certain embodiments, the microfluidic device may be used for labeling, sensing, differentiating, and/or sorting cell populations.

Microfluidic cell sensors and actuators can provide cell sensing and counting for a more accurate outcome and a lower cost. Particle counting (including bead, erythrocyte, and cultured cell) has been demonstrated, for example, by electrical impedance sensing, light scattering detection, and fluorescent sensing. Gawad, et al. Lab Chip 1 ; 76 (2001); Lee, et al. Proceedings of the 1$h IEEE International Conference on Micro Electro Mechanical Systems (MEMS) 678-681 (2005); Satake et al. Sens. Actuators B: Chem. 83; 77 (2002); Morgan, et al. Curr. Appl. Phys. 6, 367-370 (2006); Lee et al., J. Micromech. Microeng. 15; 447-454 (2005); Altendorf, et al. Proceedings of the International Conference on Solid State Sensors and Actuators (Transducers '97) v.1 , p. 531 , Chicago, IL (1997); Holmes et al., Biosens. Bioelectron. 21; 1621-1630 (2006); Yang et al., Meas. ScL Technol. 17; 2001-2009 (2006); Simonnet et al., Anal. Chem. 78; 5653-5663 (2006); Niehren, et al., Anal. Chem. 67; 2666-2671 (1995).

In the area of optical sensing, microfabrication has allowed development of microdevices to replace glass capillary-based flow chambers, and to integrate compact optics and provide on-chip sample transport.

Cell sensing and counting, particularly of leukocytes, is cumbersome due in part to the cell population numbers. For leukocyte differential in microdevices based on optical sensing, a V-groove microchannel was fabricated by anisotropic wet etching of a silicon substrate and 3-part leukocyte differential was demonstrated for diluted blood without sheath flow by two-parameter light scattering. Altendorf, Proceedings of the Int'l Conference on Solid State Sensors and Actuators, v. 1 , p.531 (1997).

However, until the instant embodied disclosure, it was necessary to dilute cell samples for cell sensors and actuators for many reasons. One reason dilution has been necessary is in order to prevent the coincidence effect in which multiple cells appear in the detection zone simultaneously. In human blood, the ratio of erythrocytes, or red blood cells, to leukocytes is on the order of about a thousand to one, a dilution factor of from about one hundred to several tens of thousands is typically required to avoid erythrocyte interference for electrical impedance or light scattering detection. Furthermore, for counting leukocytes in samples where leukocytes are specifically fluorescently labeled, a dilution of at least ten times is usually required. Sheenan and Storey, J. Pathol. Bacteriol. 59; 336 (1947); Kass, J. CHn, Pathol. 76; 810-12 (1981); Weigl et al., Biomed. Microdev. 3; 267-274 (2001);

Dilution is also often required in order to avoid clogging sample chambers, and also in order to remove erythrocytes that are lysed prior to running the sample, particularly for electrical impedance or light scattering detection. Some of these protocols also require an additional fixation buffer.

Dyes

In the present disclosure, a dye, such as Acridine orange (3,6- dimethylamineoacridine, FIG. 1), can be used to differentiate a target, such as cells, organelles, granules, nuclei, molecules (including double or single stranded nucleic acids, such as DNA, or RNA, chromosomes, and also including synthetic forms). In one particular embodiment, leukocytes may be detected, counted, or sorted without need for lysing erythrocytes or fixing the cell sample. Certain dyes, such as Acridine orange, are also desirable due to the fast diffusion into cells, easy commercial availability, and excitation and emission wavelength compatibility with common light sources (i.e. argon laser and other broad spectrum light sources in visible range) and optical filters. Kosenow, Acta Haematol. 7, 217 (1952); Schiffer, Blood, 19, 200 (1962); Jackson, Blood, 17, 643 (1961); Haliermann et al., Verh Deutsch Ges Inn Med. 70, 217 (1964).

Acridine orange is a pH-sensitive fluorescent cationic dye that binds to double-stranded DNA by electrostatic attraction and intercalation of the Acridine orange between base pairs. Upon binding, the excitation maximum becomes 502 nm and the emission maximum becomes 525 nm (green). Acridine orange also binds to RNA and single-stranded DNA, with a shifted excitation maximum of 460 nm and an emission maximum of 650 nm (red). Adams and Kamentsky, Acta Cytol. 15, 289 (1971); Adams and Kamentsky Acta Cytol. 18 , 389-91 (1974); Steinkam et al., Acta Cytol. 17, 113-17 (1973). Acridine orange is also desirable in that it is hydrophobic in neutral pH, and can easily diffuse through the cell membrane and cell nuclear membrane to bind to RNA and DNA. In living cells, Acridine orange is protonated in the acidic environment of lysosomes, which makes it cationic and prevents the dye from leaking out of lysosome membranes. Moriyama et al., J. Biochem. 92; 1333-36 (1982). When Acridine orange is used for leukocyte analysis, the cell nucleus is stained green with slightly mixed red, a result of double-stranded DNA and single-stranded RNA, while the cell cytoplasm is stained red due to the RNA and lysosomes. Thus, leukocyte counting can be achieved easily by using the strong signal from the green fluorescent channel. Leukocyte differentiation can be achieved by analyzing the signal from the red fluorescence channel.

For fresh-stained leukocytes, a 3-part differential (lymphocytes, monocytes, and granulocytes) can be achieved by studying the red fluorescent signal of an Acridine orange stained diluted blood sample, whereas a 5-part differential leukocytes (lymphocytes, monocytes, neutrophils, eosinophils, and basophils) has been demonstrated with hypotonic dilution and fresh Acridine orange-stained leukocyte samples. Adams and Kamentsky, Acta Cytol. 15, 289 (1971); Adams and Kamentsky, Acta Cytol. 18, 389-391 (1974); Steinkam et al., Acta Cytol. 17, 113-17 (1973). Other dyes can be utilized with certain embodiments described in the instant disclosure, such as ethidium bromide, three-dye combinations (ethidium bromide, brilliant sulfaflavine, and stilbene disulfonic acid derivative); oxazine dyes, basic orange 21 , and a polymethine dye. Shapiro, et al., J. Histochem. Cytochem. 24, 396-411 (1976); Shapiro, et al., J. Histochem. Cytochem. 25, 836-844 (1977); U.S. Patent No. 4,376,820; U.S. Patent No. 4,882,284; Tibbe, et al., Nat. Biotechnol. 17, 1210-1213 (1999); U.S. Patent No. 4,400,370; Kass, J. Histochem. Cytochem. 36, 711-715 (1988).

Apparatus One embodiment of the instant disclosure relates to a device or apparatus for cell counting and/or differentiating. In particular embodiments, the device or apparatus comprises a substrate formed from a material, such as silicon, glass, plastic, metal, or other material. One particular embodiment of the instant disclosure was fabricated using soft lithography. Quake, Science 290, 1536-40 (2000). Other photolithographic or etching techniques could also be used, according to specific embodiments.

One embodiment of the device was microfabricated using two parts of PDMS (polydimethylsiloxane) (Sylgard 184, Dow Corning, Ml, USA) mixed vigorously in 10:1 ratio. After degassing in vacuum for about 30 minutes, the mixture was poured onto DRIE-eteched silicon mold, that had been pretreated with HMDS (hexamethyldisilazane) for easy separation after baking. The molds were baked at 8O0C for 30 minutes. The hardened PDMS was separated from the silicon mold, and PDMS sheet was cut into pieces and fluidic access holes were punctured on each piece with a Luer stub adapter (Becton Dickinson, NJ, USA). Each PDMS piece was carefully placed on a cleaned glass slide and baked overnight at 8O0C. In some cases, oxygen plasma treatment (300 m Torr, 25 W, 30 s) was used for PDMS and glass slides in order to improve adhesion between them, particularly with devices that were intended to be reused. Bhattacharya et al., J. Microelectromechan. Syst. 14, 590-97 (2005).

In one particular embodiment, the channel structure was molded on a 1 cm x 1 cm PDMS block, with the thickness of the PDMS block at less than 3 mm. in one particular embodiment the channel depth was 16 μm in order to accommodate large leukocyte sizes. One exemplary embodiment of the device is shown in FIG. 2. For this particular embodiment, a first fluid flow inlet 200 allows for deposition of, for example sheath flow fluid, and is in fluid communication with a bifurcated channel with a first channel arm 260 and a second channel arm 270 that both converge at a junction of a reservoir 290 and the detection zone 240. In this particular embodiment, the apparatus further comprises a second fluid flow inlet 210 that allows for deposition of, for example, a sample fluid, such as blood, that is in fluid communication with a filter array structure 230, by way of a branched sample flow zone channel 220 and a fluid flow outlet 250. In this particular exemplary embodiment, 2-D hydrodynamic focusing was adopted to control the particle position of the cell sample in the detection zone 240. According to the embodiment shown in FIG. 2, the ratio of cross-sectional area of sheath flow to core sample flow was 10:1 , and the channel width of the detection zone 240 was 50 μm, with the width of the focused sample flow preferably 5μm or less. In particular embodiments, the channels comprise a physical feature, such as a depression or a protrusion.

One other exemplary embodiment of the device is shown in FIG. 13A. For this particular embodiment, the fluid flow inlet 1340 allows for deposition of a sample fluid, such as a biological sample, or other fluid sample containing a target.

In one particular embodiment, the biological sample includes a cell sample, such as blood. In this exemplary embodiment, the fluid inlet is in fluid communication with a first channel 1330 which contains a restrictive access 1320 that is juxtaposed to a second channel 1310 which comprises the detection zone which is also in fluid communication with the fluid flow outlet 1300. In certain embodiments, the height of the first and/or second channels is approximately 5 μm, approximately 8 μm, approximately 10 μm, approximately 12 μm, approximately 15 μm, approximately 20 μm, approximately 25 μm, approximately 30 μm, approximately 35 μm, approximately 40 μm, or any value therebetween. In certain embodiments, the width of the second channel is approximately 5 μm, 10 μm, approximately 15 μm, approximately 20 μm, approximately 25 μm, approximately 30 μm, approximately 35 μm, approximately 40 μm, approximately 45 μm, approximately 50 μm, or any value therebetween. In the exemplary embodiment shown in FIG. 13A, the second channel width was approximately 20 μm in size.

One other exemplary embodiment of the device is shown in FIG. 13B. For this particular embodiment, the fluid flow inlet 1440 allows for deposition of a sample fluid, such as a biological sample, or other fluid sample containing a target. In one particular embodiment, the biological sample includes a cell sample, such as blood. In this exemplary embodiment, the fluid inlet is in fluid communication with a first channel 1430 which contains a restrictive access 1420 that is juxtaposed to a second channel 1410 which comprises the detection zone which is also in fluid communication with the fluid flow outlet 1400. In certain embodiments, the height of the first and/or second channels is approximately 5 μm, approximately 8 μm, approximately 10 μm, approximately 12 μm, approximately 15 μm, approximately 20 μm, approximately 25 μm, approximately 30 μm, approximately 35 μm, approximately 40 μm, or any value therebetween. In certain embodiments, the width of the second channel is approximately 5 μm, 10 μm, approximately 15 μm, approximately 20 μm, approximately 25 μm, approximately 30 μm, approximately 35 μm, approximately 40 μm, approximately 45 μm, approximately 50 μm, or any value therebetween. In the exemplary embodiment shown in FIG. 13B, the second channel width was approximately 30 μm in size.

Certain embodiments of the device use a focused laser source for illumination, since cell focusing in the detection zone 240 is highly desirable. However, other embodiments included in the present disclosure use a more uniform diffused light source and a slit aperture. Such embodiments utilize straight channel geometry without cell focusing. In one embodiment, the channel length of the detection zone 240 is 1000 μm. A filter structure 230 upstream of the sample flow zone 220 may also be included in certain embodiments, which filtered out contaminants, including erythrocyte rouleaux, and other large particle aggregates to prevent clogging in the detection zone 240. In certain embodiments, the size of the rectangular pillar structure components of the filter structure 230 was 200 μm x 40 μm. The spacing between the pillars in each of the three rows was 40 μm, 30 μm, and 20 μm respectively, which allows for even the largest leukocytes to pass through the filter region 230.

System

The optical system was set up on an optical bench as shown in FIG. 3 (transmitted laser-induced fluorescent detection system or LIF). In one particular embodiment, the system setup comprises an excitation or laser source 300, a lens assembly 340, the microfluidic apparatus 350, an optional additional lens assembly 360, a filter assembly 320, 330, and an image capture device 390, 395. In certain embodiments, one or more emission filters comprise the filter assemblies 320, 330. In certain embodiments, the image capture device 395 comprises a charge coupled device (CCD) camera, a complementary metal-oxide-semiconductor (CMOS) device, or a photomultiplier tube (PMT) device. In particular embodiments, the image capture device 395 may be coupled to communicate with a display unit or computing device 396, such as a personal computer. One of skill in the art would recognize that multiple and various computer software programs are available that allow for integration, compilation, analysis, reconfiguration, and other manipulation of data received from the system, particularly by way of the computing device 396.

In one particular exemplary embodiment, an argon laser (National Laser NLC210BL, 488 nm, and 15-30 mW adjustable, Salt Lake City, UT, USA) is used as the excitation source. An aperture 310 of 50 μm diameter is put in front of the laser output to facilitate the alignment process and lower the illumination intensity. In certain embodiments, an optional laser-line bandpass filter (bandwith equal to about 1.9 nm with a central wavelength of 488 nm) is used to further purify the laser source. In certain other embodiments, an optional neutral density filter (NDF) is used to attenuate laser excitation. Alternatively, the pinhole and NDF are replaced by two linear glass polarizers (Edmond Optics TECH SPEC, Barrington, NJ, USA) so that the illumination level on the device can be easily adjusted.

In one particular embodiment, a long-working-distance microscope objective (USMCO M Plan Apo, 1Ox, 0.28 NA, Dayton, NV, USA) is used as a condenser lens 340. Another long-working-distance microscope objective (Bausch & Lomb, 5Ox, 0.45 NA, Rochester, NY, USA) is used as an objective lens 360. In the same embodiment, three emission filters 320 are used in one particular test: 488 nm long pass filter (Chroma H 1500 LP, transition width < 4.9 nm, edge steepness = 2.5 nm, Rockingham, VT, USA), a green bandpass filter with central wavelength 525 nm and a bandwidth 50 nm (Chroma D525_50 m), and a red bandpass filter with central wavelength 650 nm and bandwidth 50 nm (Chroma D650_50 m). A broadband non-polarizing hybrid cube beamsplitter 370 (Newport 05BC17MB.1 , 400-700 nm, RTT = 45%/45%, Irvine, CA, USA) is used to direct light to the photodiode detector 380 and CCD camera simultaneously.

The signal is electrically amplified and detected either with a silicon photodiode receiver module 390 (Electro-Optical Systems, UVS-025-H, Phoenixville, PA, USA) or a photon multiplier tube (PMT, Hamamatsu H5784-20,

Japan). The voltage signal is sent to a deep memory oscilloscope (HP 54645A, Palo Alto, CA1 USA). When the buffer in the oscilloscope is full, the data can be loaded to a computer and analyzed with a Matlab peak-detection program. Video may be taken with an analog CCD camera (Hitachi KP-D20B, Japan) at 30 frames per second and then converted to digital format and stored in a computer 396. Other imaging capture devices 395, such as CMOS, PMT, or still other devices may also be used with particular embodiments described herein. In certain exemplary test runs, the system set up utilizing a photodiode detector and PMT are more sensitive than the CCD camera and have a faster time response. During one exemplary test run, the optical system was first roughly aligned on a dummy device with the aid of images from CCD camera. A 10 μm diameter illumination spot on the detection zone is easily achieved with proper alignment.

As shown in FIG.12A and FIG.12B, the instant apparatus may be incorporated into a hand-held unit comprising a laser source (such as a laser emitting diode or LED 120), at least one lens 190, at least one filter assembly with optional beamsplitter 195, a microfluidic apparatus as described herein on a microchip or other substrate 185, an input/output port 130, at least one image capture device 100, 110, which may be a photomultiplier tube. In certain embodiments, the hand-held unit may be assembled and enclosed by an outer casing or casings 150, 180, and rivets or bolts 140, 160.

Cell Detection

One aspect of the instant disclosure relates to methods of counting and/or differentiating cells, particularly leukocytes, from undiluted cell samples, such as human or other animal blood, by utilizing microfabricated devices. In one exemplary embodiment, cell detection was conducted utilizing Acridine orange and fresh whole human blood.

In one exemplary embodiment, fresh human blood was obtained from healthy donors and used within 3 days of collection. EDTA was added to the blood samples in order to prevent coagulation. For Acridine orange staining, the stock solution was added to obtain a final dye concentration of 10 μg/mL in Ficoll-Paque Plus. Ficoll-Paque Plus was also used as the sheath flow solution. Fluorescent polystyrene beads (5 μm green fluorescent beads) were purchased from Duke Scientific Corporations, Fremont, CA, USA. Cell nucleus stain Acridine orange was obtained from Molecular Probes, Eugene, OR, USA, and dissolved in water to achieve a 10 mg/mL stock solution. Blood diluent Ficoll-Paque Plus was purchased from Amersham Biosciences, Sweden. Phosphate buffered saline (10 x PBS) was obtained from Ambion (9625), Austin, TX, USA.

Staining results were observed under a fluorescent microscope (Nikon E800, Japan) with a triple band filter block DAPI-FITC-TRITC, which has excitation filter wavelengths of 385-400 nm, 475-490 nm, and 545-565 nm, and emission filter wavelengths of 450-465 nm, 505-535 nm and 580-620 nm. Images were taken with a cooled CCD camera (RT-KE color 3-shot, Diagnostic Instruments, Sterling Heights, Ml, USA). Rough count of leukocytes was made with a hemactyometer (Hausser Scientific, Horsham, PA, USA). When necessary, blood or fluorescent beads were diluted with Ficoll-Paque Plus (specific gravity 1.077 g/mL) to match the specific gravity of the solvent to leukocytes. All fluids were pumped into the devices using syringe pumps (Harvard Apparatus Pico Plus, Holliston, MA, USA). In this particular embodiment, an analog CCD camera was used for video recording at a matched camera frame rate of 3 nL/min sample flow rate and 30 nL/min sheath flow rate. For photodiode detection, a 0.1 μL/minute sample flow rate and a 1 μL/minute sheath flow rate were used. A 1 μL/minute sample flow and a 10 μL/minute sheath flow were used with the photon multiplier tube instrument.

In order to achieve a high signal-to-noise ratio, the maximal concentration for cell staining was established using routine methods in the art. Adams and Kamentsky, Acta Cytol. 15; 289 (1971). As shown in FIG. 4, whole blood samples were analyzed with different Acridine orange concentrations. The optimal concentration for leukocyte staining was determined to be approximately in the range of 1 μg/mL In the particular exemplary embodiment utilized in FIG. 4, the distance between the coverslip and the grid surface was approximately 100 μm. As can be seen in FIG. 4A1 an abundance of erythrocytes were present under the field of view, yet these cells did not interfere with the fluorescent signal from the leukocytes, as shown in FIG. 4B-F.

As can be seen in FIG. 5, the exemplary embodiment utilized in cell detection did not experience any significant photobleaching. The signal was fitted as a first-order exponential decay with time constant of 6.4 +/- 0.7 seconds. Two more tests confirmed that the photobleaching time constant for one particular embodiment was between 1 second and 10 seconds. The photobleaching time constant for one particular embodiment was characterized by filling the device with Acridine orange-stained whole blood. The channel was scanned by the laser spot and the illumination was set to be the same as that used in testing. The entire process was recorded with a CCD camera. Whenever a fluorescing leukocyte was observed with fluorescent emission clearly distinct from the background, we stopped moving the laser spot and waited until the leukocyte was photobleached to background level. The images were extracted from the video, converted to 8-bit gray scale images, and analyzed with a Matlab program. The data was fitted to a single time-constant exponential decay.

Additionally, green fluorescent beads were tested at a concentration of about 2 x 103/μl_, as observed by CCD camera, and shown in FIG. 6. Sample flow rate was set at about 3 nL/min, and sheath flow was about 30 nL/min. In one exemplary test run, a hydrodynamic focused laser beam, as shown in FIG. 6A, created an enlarged light circle as shown in FIG. 6B. Only a single bead normally appeared in each image. With diffused laser illumination, as shown in FIG. 6C, the trace of the bead could be identified, as shown in FIG. 6D. Hydrodynamic focusing limits the cross-sectional area of the detection zone without shrinking the channel diameter, thus the signal-to-noise ratio may be improved without increasing the risk of clogging the channel. Also, the reduction of the cross-section of the core flow reduces the coincidence effect. Finally, enclosing the core sample flow with sheath flow minimizes fluorescent dye absorption in the device walls, thus reducing background noise. As indicated in FIG. 7, bead signals from the photodiode detector could easily be identified.

As shown in FIG. 8, using both red and green emission filters, images extracted from video taken by the CCD camera show the signal identified from a leukocyte stained with Acridine orange, as well as the signal obtained from the fluorescent control bead. For photodiode detection, the expected leukocyte detection rate would average about 4-11 cells per second for a normal individual.

In one exemplary embodiment, a time trace over 50 seconds of an undiluted blood sample stained with Acridine orange using a green emission filter, and a throughput of up to about 1000 leukocytes per second was attained. Maxima signal intensity (peak height as in FIG. 9) from the green fluorescent channel with 525 nm emission filter was studied by plotting its histogram, as shown in FIG. 10. As expected, the lower-intensity portion is likely contributed mainly by lymphocytes, while the higher-intensity portion is likely mainly from monocytes, with the center-region is likely mostly from granulocytes. Steinkam et al., Acta Cytol. 17; 113-117 (1973). In one exemplary embodiment, a time trace over 50 seconds of an undiluted blood sample stained with Acridine orange using a red fluorescent channel with 650 nm emission filter was conducted. As shown in FIG. 11 , two peaks were identified, the lower intensity is dominated by lymphocytes and the higher-intensity peak is largely monocytes and granulocytes. The time between the start of staining the cells to photodiode recording was typically greater than 15 minutes.

In both exemplary studies, the maximal throughput was about 1000 leukocytes per second utilizing one embodiment of the PMT detector. By using undiluted blood, minimal sample volume was maintained, which increases the throughput. Since sample throughput is proportional to volume flow rate, but is limited by the maximal pumping rate and response time of the sensing system, a 3 nL/minute core flow rate was used with the CCD camera detection. Under this flow rate, a typical leukocyte traveled through the detection zone in approximately 30 milliseconds, which roughly equals the CCD frame acquisition time. Flow rates for varying embodiments may be suitable for a range from approximately 1 nL/minute, approximately 2 nL/minute, approximately 3 nL/minute, approximately 4 nL/minute, approximately 5 nL/minute, approximately 6 nl_/minute, approximately 7 nL/minute, approximately 8 nL/minute, approximately 9 nL/minute, approximately 10 nL/minute, approximately 20 nL/minute, approximately 30 nL/minute, approximately 40 nL/minute, approximately 50 nL/minute, approximately 60 nL/minute, approximately 70 nL/minute, approximately 80 nL/minute, approximately 90 nL/minute, approximately 100 nL/minute, approximately 110 nL/minute, approximately 120 nL/minute, approximately 130 nL/minute, approximately 140 nL/minute, approximately 150 nL/minute, or any value therebetween for photodiode detection. Likewise, for PMT detection, flow rates for varying embodiments may be suitable for a range from approximately 200 nL/minute, approximately 300 nL/minute, approximately 400 nL/minute, approximately 500 nL/minute, approximately 600 nL/minute, approximately 700 nL/minute, approximately 800 nL/minute, approximately 900 nL/minute, approximately 1 μL/minute, approximately 2 μL/minute, approximately 3 μL/minute, approximately 4 μL/minute, approximately δμUminute, or any value therebetween.

In one exemplary embodiment, the time response of the photodiode receiver module under low sensitivity setting was 0.16 milliseconds, and 0.6 milliseconds under high sensitivity, while the time response of the PMT detector in one exemplary run was about 16 microseconds.

Furthermore, by decreasing the cross-sectional area, the linear flow velocity of the core flow is increased, which requires faster sensing, and reduces the coincidence effect by increasing the average distance between cells in the detection zone. Thus, by utilizing particular embodiments disclosed herein relating to a microfluidic device, leukocyte sensing, counting, and sorting can be achieved one- by-one in a micro flow cytometer system. Furthermore, dense cell suspensions, such as whole, undiluted blood may be utilized in certain embodiments described herein, which provides for reduced sample and waste volume, reduced processing time, and completely eliminates on-chip mixing and buffer storage. In particular aspects, leukocytes can be sensed one-by-one in a micro flow cytometer system.

As described herein, certain embodiments of the device can be implemented in various sizes and conformations, including but not limited to a bench-top device, a handheld device (such as is shown in FIG. 12), an implantable device, a nanotechnology device, or other size or conformation. In the smaller exemplary conformations, high-illumination LED is used for excitation and a minipump is used to manipulate the sample in suction mode, while fluorescent signals from green and red channels can be detected simultaneously.

Incorporation by Reference

All of the above U.S. patents, U.S. patent application publications, U.S. patent applications, foreign patents, foreign patent applications and non-patent publications referred to in this specification and/or listed in the Application Data Sheet, are incorporated herein by reference, in their entirety.

Claims

1. A microfluidic apparatus comprising a substrate with a first channel having a defined physical feature, wherein said first channel is in fluid communication with at least one inlet for receiving a fluid, wherein said first channel leads to a restrictive access, and wherein said first channel is in fluid communication with a second channel having a defined physical feature, wherein said second channel is in fluid communication with at least one fluid flow outlet; and a fluid biological sample.
2. The microfluidic apparatus of claim 1 wherein said defined physical feature is a depression or protrusion.
3. The microfluidic apparatus of claim 1 , wherein said fluid biological sample comprises blood.
4. The microfluidic apparatus of claim 1 , further comprising a detection zone in fluid communication with said channel and said fluid flow outlet.
5. A microfluidic apparatus comprising a substrate with a first channel having a defined physical feature; a first inlet formed in said first channel for receiving a first fluid; wherein said first channel is in fluid communication with a bifurcated second channel, wherein said bifurcated channel is in fluid communication with a third channel detection zone; at least one second inlet for receiving a second fluid, wherein said second inlet is in fluid communication with a branched channel; a filter structure in fluid communication with a reservoir, wherein said reservoir is in fluid communication with said third channel detection zone; at least one fluid flow outlet formed in said third channel; and a fluid sample; wherein the ratio of the cross-sectional area of said second channel compared to the cross-sectional area of said first channel is 1 : 10.
6. The microfluidic apparatus of claim 5 wherein said defined physical feature is a depression or a protrusion.
7. The microfluidic apparatus of claim 5, wherein said filter structure comprises a filter array.
8. The microfluidic apparatus of claim 5, wherein said first fluid comprises sheath fluid and said second fluid comprises blood.
9. A detection system comprising the microfluidic apparatus of claim 1 or claim 5 and further comprising a light source; a lens assembly; a filter assembly; and an image capture device.
10. The detection system of claim 9, further comprising at least one display unit or at least one recording unit.
11. The detection system of claim 9, wherein said excitation source comprises a laser.
12. The detection system of claim 11 , wherein said laser comprises an argon laser.
13. The detection system of claim 9, wherein said filter assembly comprises an excitation filter, and at least one emission filter.
14. The detection system of claim 13, wherein said filter assembly further comprises at least one aperture and at least one neutral density filter.
15. The detection system of claim 13, wherein said filter assembly further comprises at least one glass polarizer.
16. The detection system of claim 9, wherein said lens assembly comprises at least one condenser lens, at least one objective lens, and at least one beamsplitter.
17. The detection system of claim 9, wherein said image capture device comprises at least one CCD camera, CMOS device, photodiode, or photomultiplier tube.
18. The detection system of claim 9, wherein said filter assembly comprises at least two emission filters and said image capture device comprises at least one photomultiplier tube.
19. The detection system of claim 9, wherein said display unit comprises a computer and said recording unit comprises an oscilloscope.
20. The detection system of claim 9, wherein said excitation source comprises an argon laser; said lens assembly comprises a condenser lens, an objective lens, and a beamsplitter; said filter assembly comprises an excitation filter, a pinhole aperture and a neutral density filter, and at least one emission filter; said image capture device comprises a CCD camera and a photodiode, and said display unit comprises a personal computer, and further comprising an amplifier.
21. The detection system of claim 9, wherein said excitation source comprises an argon laser; said lens assembly comprises a condenser lens, an objective lens, and a beamsplitter, said filter assembly comprises an excitation filter, at least one emission filter; said image capture device comprises a photomultiplier tube, and said display unit comprises a personal computer.
22. A method for identifying a target comprising providing a fluid sample to at least one microfluidic apparatus, wherein said fluid sample contains at least one dye; providing an excitation source to induce at least one fluorescent signal in a target; detecting the fluorescent signal using a sensor in the apparatus; and identifying the target based in part on the analysis of the fluorescent signal.
23. The method of claim 22 wherein said target is selected from the group consisting of: cells, organelles, nuclei, granules, DNA, and RNA.
24. The method of claim 22 wherein said target comprises a cell selected from the group consisting of a monocyte, a granulocyte, a macrophage, a neutrophil, an eosinophil, a basophil, or other leukocyte.
25. The method of claim 22 wherein said target comprises a leukocyte and said dye comprises acridine orange.
26. The method of claim 22 further comprising counting or sorting the target in the sample by analysis of the fluorescent signal.
27. The method of claim 22, wherein said fluid sample comprises blood.
PCT/US2008/059408 2007-04-06 2008-04-04 Microfluidic device WO2008124589A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US92229607P true 2007-04-06 2007-04-06
US60/922,296 2007-04-06

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN200880015296.7A CN101678356B (en) 2007-04-06 2008-04-04 Microfluidic device
EP08733132A EP2134471A2 (en) 2007-04-06 2008-04-04 Microfluidic device

Publications (2)

Publication Number Publication Date
WO2008124589A2 true WO2008124589A2 (en) 2008-10-16
WO2008124589A3 WO2008124589A3 (en) 2008-12-11

Family

ID=39596812

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/059408 WO2008124589A2 (en) 2007-04-06 2008-04-04 Microfluidic device

Country Status (5)

Country Link
US (5) US20090042241A1 (en)
EP (1) EP2134471A2 (en)
CN (2) CN101678356B (en)
HK (1) HK1200754A1 (en)
WO (1) WO2008124589A2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011128893A2 (en) 2010-04-15 2011-10-20 Leukodx Ltd. Device, system and method for rapid determination of a medical condition
US8945913B2 (en) 2012-12-17 2015-02-03 Leukodx Ltd. Kits, compositions and methods for detecting a biological condition
US9029158B2 (en) 2007-04-06 2015-05-12 California Institute Of Technology Microfluidic device
DE102014203285A1 (en) * 2014-02-24 2015-08-27 Miltenyi Biotec Gmbh Hydrodynamic focusing unit

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2483402B (en) * 2009-06-04 2014-04-09 Lockheed Corp Multiple-sample microfluidic chip for DNA analysis
CN101914435B (en) * 2010-05-24 2013-08-21 博奥生物有限公司 Microtube device and using method thereof
WO2012051529A1 (en) 2010-10-15 2012-04-19 Lockheed Martin Corporation Micro fluidic optic design
SG194064A1 (en) * 2011-04-08 2013-11-29 Panasonic Corp Diagnosis kit and method of using the same
WO2013028980A1 (en) * 2011-08-24 2013-02-28 Abbott Point Of Care, Inc. Biologic fluid sample analysis cartridge
CN103091230B (en) * 2011-10-31 2016-08-24 深圳迈瑞生物医疗电子股份有限公司 One kind of sheath flow impedance counting means and the sheath flow impedance counting method
US20130137135A1 (en) 2011-11-28 2013-05-30 California Institute Of Technology Compositions and methods for leukocyte differential counting
CN103160430A (en) 2011-12-13 2013-06-19 三星电子株式会社 Cell capturing filter having high aspect ratio
US9322054B2 (en) 2012-02-22 2016-04-26 Lockheed Martin Corporation Microfluidic cartridge
CN102998242B (en) * 2012-11-25 2014-06-18 中北大学 Micro-fluid cytometer and manufacture method thereof
CN105408022B (en) * 2013-05-14 2018-03-30 哈佛学院院长等 For quickly producing the apparatus and method of droplet
CN103341372A (en) * 2013-07-05 2013-10-09 西北工业大学 Micro-fluidic chip structure for flow cytometer, and preparation method of micro-fluidic chip
US8961904B2 (en) 2013-07-16 2015-02-24 Premium Genetics (Uk) Ltd. Microfluidic chip
EP3022544A4 (en) * 2013-07-16 2017-06-21 Premium Genetics (UK) Ltd. Microfluidic chip
US9464994B2 (en) 2013-07-30 2016-10-11 Clemson University High sensitivity tunable radio frequency sensors
CA2929275A1 (en) 2013-10-30 2015-05-07 Premium Genetics (Uk) Ltd. Microfluidic system and method with focused energy apparatus
JP2015166707A (en) * 2014-03-04 2015-09-24 キヤノン株式会社 microchannel device
KR101605518B1 (en) * 2014-10-24 2016-03-22 주식회사 센플러스 Device and method for a high-throughput self-assembly of micro particles in microfluidic channel
CN104388299B (en) * 2014-10-30 2016-03-16 东南大学 Microfluidic chip for a cell capture
JP2018501083A (en) * 2014-11-03 2018-01-18 ザ ジェネラル ホスピタル コーポレイション Concentration of particles in microfluidic devices
TWI560269B (en) * 2015-02-13 2016-12-01
EP3307670A4 (en) 2015-06-12 2019-02-27 Cytochip Inc. Fluidic units and cartridges for multi-analyte analysis
US10077999B2 (en) 2015-07-14 2018-09-18 Cytochip Inc. Volume sensing in fluidic cartridge
CN105424261B (en) * 2015-12-08 2018-05-04 上海交通大学 A kind of flexible MEMS pressures in bubbles sensor and its application and preparation method
CN105823815B (en) * 2016-01-04 2018-06-26 浙江农林大学 Anticancer drug docetaxel Composition analyzed device and detection method
WO2017127120A1 (en) * 2016-01-22 2017-07-27 Hewlett-Packard Development Company, L.P. Fluid sensing with control of particle aggregation in sensing zone

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837115A (en) * 1993-06-08 1998-11-17 British Technology Group Usa Inc. Microlithographic array for macromolecule and cell fractionation
US20060011862A1 (en) * 2004-07-16 2006-01-19 The Charles Stark Draper Laboratory, Inc. Methods and apparatus for biomolecule identification

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4233029A (en) * 1978-10-25 1980-11-11 Eastman Kodak Company Liquid transport device and method
IT1123573B (en) 1979-09-10 1986-04-30 Anic Spa Composition suitable for the control of tissues and / or liquid biiologici and method employing the same
US4400370A (en) 1980-03-12 1983-08-23 Lawrence Kass Metachromatic dye sorption means for differential determination of leukocytes
JPH0544101B2 (en) 1982-10-14 1993-07-05 Mitsubishi Electric Corp
JPH0823558B2 (en) 1984-11-27 1996-03-06 オ−ジエニクス リミテツド Test equipment
US4745285B1 (en) 1986-08-21 1992-08-11 Becton Dickinson Co
US4882284A (en) 1987-04-13 1989-11-21 Ortho Pharmaceutical Corporation Method for quantitating and differentiating white blood cells
DE68925602T2 (en) 1988-08-02 1996-11-14 Abbott Lab Method and apparatus for generating calibration data for the analysis
US5304487A (en) * 1992-05-01 1994-04-19 Trustees Of The University Of Pennsylvania Fluid handling in mesoscale analytical devices
US5637469A (en) 1992-05-01 1997-06-10 Trustees Of The University Of Pennsylvania Methods and apparatus for the detection of an analyte utilizing mesoscale flow systems
EP0839318B1 (en) 1995-06-16 2003-05-07 University of Washington Microfabricated differential extraction device and method
US6168948B1 (en) 1995-06-29 2001-01-02 Affymetrix, Inc. Miniaturized genetic analysis systems and methods
US7403804B2 (en) 2001-04-11 2008-07-22 Trutouch Technologies, Inc. Noninvasive determination of alcohol in tissue
US5716852A (en) 1996-03-29 1998-02-10 University Of Washington Microfabricated diffusion-based chemical sensor
US6184978B1 (en) 1996-05-15 2001-02-06 International Remote Imaging Systems, Inc. Method and apparatus for verifying uniform flow of a fluid sample through a flow cell and distribution on a slide
US6426230B1 (en) 1997-08-01 2002-07-30 Qualigen, Inc. Disposable diagnostic device and method
WO1999060397A1 (en) 1998-05-18 1999-11-25 University Of Washington Liquid analysis cartridge
US20010008760A1 (en) 1998-08-25 2001-07-19 Chester F. King Reagent system and kit for detecting hiv infected cells
US6637463B1 (en) * 1998-10-13 2003-10-28 Biomicro Systems, Inc. Multi-channel microfluidic system design with balanced fluid flow distribution
US6136610A (en) 1998-11-23 2000-10-24 Praxsys Biosystems, Inc. Method and apparatus for performing a lateral flow assay
US6635163B1 (en) * 1999-06-01 2003-10-21 Cornell Research Foundation, Inc. Entropic trapping and sieving of molecules
KR20020043553A (en) * 1999-08-12 2002-06-10 죠지 엘. 크레이그 Microfluidic devices for the controlled manipulation of small volumes
US6524456B1 (en) * 1999-08-12 2003-02-25 Ut-Battelle, Llc Microfluidic devices for the controlled manipulation of small volumes
US6696022B1 (en) * 1999-08-13 2004-02-24 U.S. Genomics, Inc. Methods and apparatuses for stretching polymers
US6488896B2 (en) 2000-03-14 2002-12-03 Micronics, Inc. Microfluidic analysis cartridge
CN1214340C (en) 2000-04-24 2005-08-10 国际遥距成象系统公司 Multi-neural net imaging appts. and method
US7236623B2 (en) 2000-04-24 2007-06-26 International Remote Imaging Systems, Inc. Analyte recognition for urinalysis diagnostic system
US7553453B2 (en) 2000-06-02 2009-06-30 Honeywell International Inc. Assay implementation in a microfluidic format
US7630063B2 (en) 2000-08-02 2009-12-08 Honeywell International Inc. Miniaturized cytometer for detecting multiple species in a sample
US6372516B1 (en) 2000-09-07 2002-04-16 Sun Biomedical Laboratories, Inc. Lateral flow test device
EP1368653B1 (en) 2001-03-12 2013-01-23 Cellomics, Inc. Methods to increase the capacity of high content cell-based screening assays
US20020159920A1 (en) * 2001-04-03 2002-10-31 Weigl Bernhard H. Multiple redundant microfluidic structures cross reference to related applications
US7105355B2 (en) * 2001-07-18 2006-09-12 The Regents Of The University Of Michigan Flow cytometers and detection system of lesser size
EP1424549A1 (en) 2001-08-07 2004-06-02 Mitsubishi Chemical Corporation SURFACE PLASMON RESONANCE SENSOR CHIP&comma; AND SAMPLE ANALYSIS METHOD AND ANALYSIS APPARATUS USING THE SAME
US20030073089A1 (en) 2001-10-16 2003-04-17 Mauze Ganapati R. Companion cartridge for disposable diagnostic sensing platforms
US7247274B1 (en) * 2001-11-13 2007-07-24 Caliper Technologies Corp. Prevention of precipitate blockage in microfluidic channels
US7347976B2 (en) * 2001-12-20 2008-03-25 3M Innovative Properties Company Methods and devices for removal of organic molecules from biological mixtures using a hydrophilic solid support in a hydrophobic matrix
US7192560B2 (en) * 2001-12-20 2007-03-20 3M Innovative Properties Company Methods and devices for removal of organic molecules from biological mixtures using anion exchange
US7419821B2 (en) 2002-03-05 2008-09-02 I-Stat Corporation Apparatus and methods for analyte measurement and immunoassay
US7223371B2 (en) 2002-03-14 2007-05-29 Micronics, Inc. Microfluidic channel network device
US6843263B2 (en) 2002-06-24 2005-01-18 Industrial Technology Research Institute Partially closed microfluidic system and microfluidic driving method
US7319907B2 (en) 2002-11-18 2008-01-15 International Remote Imaging Systems, Inc. Multi-level controller system
US6897954B2 (en) 2002-12-20 2005-05-24 Becton, Dickinson And Company Instrument setup system for a fluorescence analyzer
US20050221281A1 (en) 2003-01-08 2005-10-06 Ho Winston Z Self-contained microfluidic biochip and apparatus
US7419638B2 (en) 2003-01-14 2008-09-02 Micronics, Inc. Microfluidic devices for fluid manipulation and analysis
EP1603674B1 (en) 2003-02-05 2016-01-06 Iquum, Inc. Sample processing
US7099778B2 (en) 2003-12-30 2006-08-29 Caliper Life Sciences, Inc. Method for determining diffusivity and molecular weight in a microfluidic device
WO2005098379A1 (en) 2004-04-08 2005-10-20 Purdue Research Foundation Multi-spectral detector and analysis system
US8071051B2 (en) 2004-05-14 2011-12-06 Honeywell International Inc. Portable sample analyzer cartridge
US8097225B2 (en) 2004-07-28 2012-01-17 Honeywell International Inc. Microfluidic cartridge with reservoirs for increased shelf life of installed reagents
US7704730B2 (en) 2004-10-14 2010-04-27 Meso Scale Technologies, Llc Multiplexed assay methods
EP1836557A4 (en) 2004-11-19 2009-01-21 Trillium Diagnostics Llc SOFTWARE INTEGRATED FLOW CYTOMETRIC ASSAY FOR QUANTIFICATION OF THE HUMAN POLYMORPHONUCLEAR LEUKOCYTE Fc RI RECEPTOR (CD64)
JP4927817B2 (en) * 2005-04-14 2012-05-09 ギロス・パテント・エービーGyros Patent AB Microfluidic device with multiple valves
US9056291B2 (en) 2005-11-30 2015-06-16 Micronics, Inc. Microfluidic reactor system
JP5415253B2 (en) 2006-03-24 2014-02-12 ハンディラブ・インコーポレーテッド Integrated system for processing microfluidic samples and methods of use thereof
US7470403B2 (en) * 2006-04-26 2008-12-30 Wisconsin Alumni Research Foundation Microfluidic platform and method of generating a gradient therein
US7705280B2 (en) 2006-07-25 2010-04-27 The Board Of Trustees Of The University Of Illinois Multispectral plasmonic crystal sensors
CN101679018A (en) 2007-01-12 2010-03-24 环境生物技术Crc控股有限公司 Sample handling device
EP2136922B1 (en) 2007-03-28 2012-12-05 BioNano Genomics, Inc. Methods of macromolecular analysis using nanochannel arrays
US20090042241A1 (en) 2007-04-06 2009-02-12 California Institute Of Technology Microfluidic device
CN101081261B (en) 2007-04-25 2010-05-19 赵清鹏 Medicine for treating hemorrhoids
EP2128617A1 (en) 2008-05-27 2009-12-02 Philips Electronics N.V. Device and methods for detecting analytes in saliva
USD621060S1 (en) 2008-07-14 2010-08-03 Handylab, Inc. Microfluidic cartridge
US8158082B2 (en) 2008-08-29 2012-04-17 Incube Labs, Llc Micro-fluidic device
JP2013506855A (en) 2009-10-05 2013-02-28 ベーリンガー インゲルハイム マイクロパーツ ゲゼルシャフト ミット ベシュレンクテル ハフツングBoehringer Ingelheim microParts GmbH Method and part for joining microfluidic parts
AU2010309456B2 (en) 2009-10-21 2013-09-05 Biocartis Nv Microfluidic cartridge with parallel pneumatic interface plate
EP2528687B1 (en) 2010-01-29 2018-08-22 Micronics, Inc. System comprising a host instrument and a microfluidic cartridge for assays
EP3239717A1 (en) 2010-04-15 2017-11-01 Leukodx Ltd System and method for determination of a medical condition
WO2012037369A1 (en) 2010-09-15 2012-03-22 Mbio Diagnostics, Inc. System and method for detecting multiple molecules in one assay
WO2012092010A1 (en) 2010-12-29 2012-07-05 Abbott Point Of Care Inc. Multi-fluidic cartridges for sample analysis and methods for using same
US20130137135A1 (en) 2011-11-28 2013-05-30 California Institute Of Technology Compositions and methods for leukocyte differential counting
EP3508848A1 (en) 2012-12-17 2019-07-10 Leukodx Ltd Systems and methods for determining a chemical state

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837115A (en) * 1993-06-08 1998-11-17 British Technology Group Usa Inc. Microlithographic array for macromolecule and cell fractionation
US20060011862A1 (en) * 2004-07-16 2006-01-19 The Charles Stark Draper Laboratory, Inc. Methods and apparatus for biomolecule identification

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9535059B2 (en) 2007-04-06 2017-01-03 California Institute Of Technology Microfluidic device
US9757729B2 (en) 2007-04-06 2017-09-12 California Institute Of Technology Microfluidic device
US9029158B2 (en) 2007-04-06 2015-05-12 California Institute Of Technology Microfluidic device
US9234884B2 (en) 2007-04-06 2016-01-12 California Institute Of Technology Microfluidic device
WO2011128893A2 (en) 2010-04-15 2011-10-20 Leukodx Ltd. Device, system and method for rapid determination of a medical condition
EP3239717A1 (en) 2010-04-15 2017-11-01 Leukodx Ltd System and method for determination of a medical condition
US9989523B2 (en) 2012-12-17 2018-06-05 Leukodx Ltd. Kits, compositions and methods for detecting a biological condition
US9207239B2 (en) 2012-12-17 2015-12-08 Leukodx Ltd. Kits, compositions and methods for detecting a biological condition
US8945913B2 (en) 2012-12-17 2015-02-03 Leukodx Ltd. Kits, compositions and methods for detecting a biological condition
DE102014203285A1 (en) * 2014-02-24 2015-08-27 Miltenyi Biotec Gmbh Hydrodynamic focusing unit

Also Published As

Publication number Publication date
CN101678356B (en) 2014-04-16
US20140377742A1 (en) 2014-12-25
CN103977848B (en) 2016-08-24
CN101678356A (en) 2010-03-24
EP2134471A2 (en) 2009-12-23
US20150309011A1 (en) 2015-10-29
US20090042241A1 (en) 2009-02-12
US9535059B2 (en) 2017-01-03
US9234884B2 (en) 2016-01-12
WO2008124589A3 (en) 2008-12-11
US9029158B2 (en) 2015-05-12
HK1200754A1 (en) 2015-08-14
US20160131640A1 (en) 2016-05-12
US20170136463A1 (en) 2017-05-18
CN103977848A (en) 2014-08-13
US9757729B2 (en) 2017-09-12

Similar Documents

Publication Publication Date Title
JP5945282B2 (en) System and method for maximizing sample usage
US7911617B2 (en) Miniaturized cytometer for detecting multiple species in a sample
CN1181343C (en) Method and apparatus for performing chemical, qualitative, quantitative and semi-quantitative analysis of urine sample
EP0022670B1 (en) Method and apparatus for automated identification and enumeration of specified blood cell subclasses
EP1070251B1 (en) Apparatus for analyzing substantially undiluted samples of biologic fluids
KR100258394B1 (en) Methods for the identification and characterization of reticulocytes in whole blood
ES2643836T3 (en) Disposable chamber to analyze biological fluids
Piyasena et al. The intersection of flow cytometry with microfluidics and microfabrication
US8540946B2 (en) Portable sample analyzer cartridge
US20020149766A1 (en) Split focusing cytometer
EP2320228B1 (en) Reticulocyte count
DE60034370T2 (en) Method and device for analyzing cells in a full blood test
US5948686A (en) Method for performing blood cell counts
US6524858B1 (en) Single channel, single dilution detection method for the identification and quantification of blood cells and platelets in a whole blood sample using an automated hematology analyzer
US20030044832A1 (en) Microflow system for particle separation and analysis
JP4621249B2 (en) Sample analysis system
US7553453B2 (en) Assay implementation in a microfluidic format
US9810707B2 (en) Chip-based flow cytometer type systems for analyzing fluorescently tagged particles
Boyle et al. Emerging technologies for point-of-care CD4 T-lymphocyte counting
EP2443427B1 (en) Method and apparatus for quantitative microimaging
ES2215181T3 (en) Rapid analysis procedure and simultaneado of nucleated red blood cells.
JP5709894B2 (en) Biological fluid analysis cartridge
US6127184A (en) Calibration of a whole blood sample analyzer
CN102472702B (en) Method for detecting particles in samples
US9495742B2 (en) Analysis and sorting of objects in flow

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880015296.7

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08733132

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase in:

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2008733132

Country of ref document: EP